POC(Point-of-Care) 진단 : 기술 및 세계 시장

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

The North American market for point-of-care diagnostics is expected to grow from $16.8 billion in 2024 to $27.7 billion by the end of 2029, at a CAGR of 10.5% from 2024 through 2029.

The Asia-Pacific market for point-of-care diagnostics is expected to grow from $9.1 billion in 2024 to $15.4 billion by the end of 2029, at a CAGR of 11.2% from 2024 through 2029.

Report Scope

The point-of-care diagnostics market is extensive and constantly evolving with new technologies and methodologies. This report explores the current and future market potential, competitive environment, regulatory scenario, and market trends, including projections through 2029 and an analysis of key players.

This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including alcohol and drug abuse, blood gas electrolyte and metabolite (BGEM), cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, and urine chemistry, and it includes comprehensive regional analyses.

The report highlights ongoing R&D efforts focused on improving accuracy accessibility and incorporating innovative diagnostic procedures. It provides insights into market drivers, challenges, opportunities, industry status, developments, trends, and strategies like mergers, acquisitions, and collaborations. It is a valuable resource for market players, potential entrants, government agencies, and other stakeholders, especially those interested in geographic expansion.

Report Includes

• 98 data tables and 46 additional tables
• An overview of the global markets and technologies for point-of-care (POC) diagnostics
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the PoC diagnostics market, with market share analysis by test type, product type, end user, and region
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Coverage of government regulations and policies, R&D initiatives, exploration activities, and government programs
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Abbott, BD, Danaher Corp., Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Novel Approaches for POC
• Significance of CLIA in the United States
• Regulatory Guidelines
• Good Manufacturing Practice
• The FDA's Role in POC Testing
• Conclusion

Chapter 3 Market Dynamics

• Factors Affecting the Point-of-Care Diagnostic Market
• Market Drivers
• High Incidences of Infectious Diseases
• Growing Prevalence of Chronic Diseases
• Increasing Demand for Self-Testing
• Aging Population
• Market Restraints
• Challenges Faced by POC Manufacturers Due to Pricing Pressure
• Technical Complexity
• Lack of Specialized Training
• Market Challenges
• Challenges in Deploying Point-of-Care (POC) Diagnostics in Remote Settings
• Environmental and Contamination Challenges in Point-of-Care Diagnostics
• Market Opportunities
• Increasing R&D Budget
• Excellent Market Potential for POCT with AI and ML Integration
• Emerging Economies

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Point-of-Care Diagnostics Market, by Test Type
• Drug and Alcohol Screening
• Blood Gas Electrolyte and Metabolite (BGEM)
• Cardiac Markers
• Cholesterol Testing/Monitoring
• Glucose Testing and Monitoring
• Infectious Disease Testing
• Pregnancy and Fertility Testing
• Hemoglobin and Hemostasis
• Tumor Marker
• Urinalysis/Urine Chemistry
• Others
• Point-of-Care Diagnostics Market, by Product
• Hardware
• Software
• Point-of-Care Diagnostics Market, by End User
• Hospitals and Critical Care Settings
• Home Care Settings
• Geographic Breakdown
• Point-of-Care Diagnostics Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 5 Emerging and Upcoming Technologies in the Market

• Emerging and Upcoming Technologies
• AI in Point-of-Care Diagnostics
• CRISPR-Cas Systems
• 3D Rapid Prototyping
• Quantum Dots
• RFID (Radio-Frequency Identification) and NFC (Near Field Communication)
• Smartphone-Based Medical Imaging
• Nanomaterials in POC Devices for Pathogen Detection
• Microfluidics-Based Sensing Technologies
• Cloud-Integrated AI
• D3 Array-UTI
• EVIK DxSpheres: A Solid Assay Solution
• UNIQO 160 Automated IIFT System
• Recent Developments

Chapter 6 ESG Development

• Introduction
• Sustainability in Plastics and Bio-Based Alternatives
• ESG Risk Ratings
• The WHO Global Action Plan
• BCC Research Viewpoint

Chapter 7 Competitive Landscape

• Mergers, Acquisitions and Collaborations
• Strategic Alliances
• FDA Approvals
• Patent Analysis
• Patent Analysis, by Year
• Company Share Analysis

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBOTT
• BD
• DANAHER CORP.
• GE HEALTHCARE
• F. HOFFMANN-LA ROCHE LTD.
• MEDTRONIC
• QUEST DIAGNOSTICS INC.
• QUIDELORTHO CORP.
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.